ATORX — Alligator Bioscience AB Income Statement
0.000.00%
Last trade - 00:00
- SEK974.54m
- SEK908.83m
- SEK58.11m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4.36 | 4.35 | 12.9 | 35.7 | 58.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 219 | 149 | 155 | 228 | 307 |
Operating Profit | -215 | -144 | -142 | -193 | -249 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -210 | -143 | -142 | -193 | -249 |
Provision for Income Taxes | |||||
Net Income After Taxes | -210 | -143 | -142 | -193 | -249 |
Net Income Before Extraordinary Items | |||||
Net Income | -210 | -143 | -142 | -193 | -249 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -210 | -143 | -142 | -193 | -249 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.57 | -1.07 | -0.958 | -0.531 | -0.554 |
Dividends per Share |